戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 500作成日:2026年10月23日

2-Bromo-5-fluorobenzotrifluoride → (R)-1-(4-fluoro-2-(trifluoromethyl)phenyl)-3-methylpiperazine

https://huagongshe.com/ja/reaction/500

反応式

関与物質

役割名称HCID仕込み量
反応物2-Bromo-5-fluorobenzotrifluorideHCID 520983—
反応物2-Methylpiperazine, (R)-HCID 7330434—
試薬Sodium t-butoxideHCID 23676156—
触媒Binap, (A+-)-HCID 634876—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒TolueneHCID 1140—
生成物(R)-1-(4-fluoro-2-(trifluoromethyl)phenyl)-3-methylpiperazineHCID 6855494859%

反応条件

温度100 °C

反応手順

1-bromo-4-fluoro-2-(trifluoromethyl)benzene (10 g, 41.15 mmol), (R)-2-methylpiperazine (4.33 g, 43.21 mmol), sodium tert-butoxide (7.91 g, 82.31 mmol) and BINAP (1.025 g, 1.65 mmol) in anhydrous toluene (100 mL) was degassed under vacuum with inlet of nitrogen. TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.754 g, 0.82 mmol) was added, the mixture again degassed. The resulting suspension was stirred at 100 °C for 4 hours under nitrogen. LCMS: Product formed. Heated for a further 2 hours. LCMS: Reaction complete. Cooled and evaporated. Residue diluted with diethyl ether (75 mL), filtered through Celite and the filtrates extracted with 2M HCl (2x30 mL). The combined aqueous layers were basified with solid NaOH to pH ~10, extracted with diethyl ether (2x50 mL), the organic extracts washed with water (2x10 mL) and brine, dried over MgSO4, filtered and evaporated to give crude product (3.2g, 59%) as an orange oil which was used without further purification.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-d91c4f300cee41c898f5dc5506a9a9f7
出典メモ750 AstraZeneca ELN dataset